Pressing issues in medtech innovation will be on the agenda on the opening day of the 2024 Transcatheter Cardiovascular Therapeutics (TCT) meeting (27–30 October, Washington, DC, USA), as the TCT MedTech Innovation Forum returns for its third edition.
The full-day event, organised by a partnership among the Cardiovascular Research Foundation (CRF), Fogarty Innovation, and the US Food and Drug Administration (FDA), will features leaders from across the medtech landscape to explore the future of cardiovascular care.
The Forum features three tracks designed to give attendees a deep dive into the most critical areas of medtech innovation today:
- Global market dynamics—dissecting the global trends reshaping innovation
- Hot topics in medtech innovation—covering the most exciting technological developments
- FDA university for startups—offering tips for navigating the US regulatory process
Attendees will also witness the TCT Shark Tank Innovation Competition. The competition will showcase device concepts with the potential to revolutionise care across clinical areas. Finalists will present to a panel of expert judges competing for a US$200,000 award from the Jon DeHaan Foundation.
“Breakthrough ideas often emerge directly from patient care experiences and entrepreneurs require the tools and insights to fast-track solutions to real-world healthcare challenges,” said Juan F Granada, president and CEO of CRF. “This Forum serves as the bridge between clinical need and disruptive innovation, helping accelerate the development of treatments that will shape the future of cardiovascular medicine.”
“Innovation has the power to fundamentally change lives,” said Andrew Cleeland, CEO of Fogarty Innovation. “But to succeed, it requires ecosystem-wide support. Our partnership with CRF creates a unique platform where innovators can unite to explore opportunities, address challenges, and enhance collaboration with the goal of improving human health.”
